Blood and blood components are medical products that are majorly used in blood transfusion to serve life-saving intervention to patient suffering from bleeding disorders, chronic diseases, traumatic surgery, and rare blood diseases.
Becton, Dickinson & Co., Kidde-Fenwal Inc., Bio-Rad Laboratories, Inc., Cerus Corporation, Immucor, Beckman Coulter, Inc., bioMérieux SA, Octapharma AG, Abbott, CSL Behring LLC, MacoPharma, Shanghai RAAS, China Biologic Products Holdings, Inc., Takeda Pharmaceutical Company Limited, Grifols S.A., Bharat Serums and Vaccines Ltd., and Terumo BCT Inc.
Get Free PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
Key Market Drivers:
Growing instances of blood disorder is a prime factor fostering growth of the blood and blood components market. According to the National Institute of Health (NIH), U.S. statistics 2018, around 459,058 people suffered from leukemia, a type of blood cancer, in the U.S. in 2018. NIH also estimates that around 61,090 new cases of leukemia would be recorded in U.S. in 2021.
Increasing research &development activities for safe blood transfusion is again expected to augment growth of the market. New product launch is another major factor augmenting market growth.
Covid-19 Impact Analysis
The market of blood and blood components has witnessed negatively growth slope due to delay in non-emergency medical procedures during Covid-19 pandemic. This was done to prevent the spread of infection. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 193,657,725 cases and 4,154,660 deaths due to coronavirus disease (COVID-19) were reported till July 25, 2021, across the globe.
The blood and blood components market is expected to exhibit a CAGR of 4.7% over the forecast period owing to the advancement in the field of blood transfusion.
North America is expected to gain significant growth over the forecast period owing to the increasing FDA approval for new product launch. For instance, in December 2020, Cerus Corporation, a U.S.-based blood product company received the U.S. Food and Drug Administration (FDA) approval for its new INTERCEPT blood system for cryoprecipitation.
Ask for PDF Brochure @
Points cover in Global Blood and Blood Components Market Research Report:
Chapter 1: Overview of Global Blood and Blood Components Market (2022-2028)
Chapter 2: Market Competition by Players/Suppliers 2022 and 2028
- Manufacturing Cost Structure
- Manufacturing Process
- Industry Chain Structure
Chapter 3: Sales (Volume) and Revenue (Value) by Region (2022-2028)
- Revenue and market share
Chapter 4, 5 and 6: Global Blood and Blood Components Market by Type, Application & Players/Suppliers Profiles (2022-2028)
- Market Share by Type & Application
- Growth Rate by Type & Application
- Drivers and Opportunities
- Company Basic Information
Chapter 7, 8 and 9: Global Blood and Blood Components Manufacturing Cost, Sourcing & Marketing Strategy Analysis
- Key Raw Materials Analysis
- Upstream Raw Materials Sourcing
- Marketing Channel
Chapter 10 and 11: Blood and Blood Components Market Effect Factors Analysis and Market Size (Value and Volume) Forecast (2022-2028)
- Technology Progress/Risk
- Sales Volume, Revenue Forecast (by Type, Application & Region)
Chapter 12, 13, 14 and 15: Global Blood and Blood Components Market Research Findings and Conclusion, appendix and data source
- Methodology/Research Approach
- Data Source (Secondary Sources & Primary Sources)
- Market Size Estimation
Reasons To buy The Blood and Blood Components Market Report:
➛ In-depth analysis of the market on the global and regional levels.
➛ Major changes in market dynamics and competitive landscape.
➛ Segmentation on the basis of type, application, geography, and others.
➛ Historical and future market research in terms of size, share growth, volume, and sales.
➛ Major changes and assessment in market dynamics and developments.
➛ Emerging key segments and regions
➛ Key business strategies by major market players and their key methods.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Business Consulting Services
The global consulting services offered by Coherent Market Insigths significantly enhance overall performance helps in overcoming business challenges, enable cost savings, increase throughput, aids in aligning existing capabilities for future opportunities and help in envisioning and executing new strategies.
We help our clients to gain a competitive advantage in a market space by offering consulting services that include—but are not limited to:
- Digital business strategy
- Customer acquisition and synergy planning
- Strategic advisory and operational excellence consulting services
- Governance, risk, fraud, and compliance consulting
- Mergers and acquisitions, strategic partnering
- Business process and transformation consulting services
- Talent and engagement consulting services
- Business and transformation consulting
- Market expansion and vertical tagging